Wyeth found not negligent in Prempro trial
Last Updated: 2006-09-15 16:08:52 -0400 (Reuters Health)
LITTLE ROCK, Arkansas (Reuters) - Jurors in the first trial against Wyeth's combination hormone replacement drug Prempro found that the company was not negligent and had adequately warned patients and doctors of the risk of cancer.
The lawsuit, the first of 5,000 filed against the company to go to trial, charged that Wyeth had been negligent in testing, manufacturing and marketing the hormone replacement therapy.
The plaintiff in the case, Linda Reeves, 67, had also argued that the company had failed to warn users and doctors about the need for regular screening for cancer and heart problems.